Investors Buy Shares of Anthem (ANTM) on Weakness

Traders purchased shares of Anthem, Inc. (NYSE:ANTM) on weakness during trading on Thursday. $142.52 million flowed into the stock on the tick-up and $80.26 million flowed out of the stock on the tick-down, for a money net flow of $62.26 million into the stock. Of all companies tracked, Anthem had the 9th highest net in-flow for the day. Anthem traded down ($4.94) for the day and closed at $227.12

A number of research analysts recently commented on ANTM shares. Zacks Investment Research cut Anthem from a “buy” rating to a “hold” rating in a report on Wednesday, August 30th. BidaskClub raised Anthem from a “hold” rating to a “buy” rating in a research note on Thursday, October 26th. Morgan Stanley lifted their price objective on Anthem from $201.00 to $215.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 26th. Bank of America lifted their price objective on Anthem from $249.00 to $254.00 and gave the stock a “buy” rating in a research note on Friday, November 17th. Finally, Jefferies Group lifted their price objective on Anthem from $204.00 to $211.00 and gave the stock a “hold” rating in a research note on Friday, October 13th. Eight equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $201.07.

The company has a market cap of $58,329.57, a PE ratio of 18.23, a price-to-earnings-growth ratio of 1.78 and a beta of 0.79. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.51 and a current ratio of 1.51.

Anthem (NYSE:ANTM) last released its earnings results on Wednesday, October 25th. The company reported $2.65 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.40 by $0.25. The firm had revenue of $22.10 billion for the quarter, compared to the consensus estimate of $22.10 billion. Anthem had a return on equity of 12.97% and a net margin of 3.35%. The company’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.45 EPS. equities research analysts forecast that Anthem, Inc. will post 11.97 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 21st. Stockholders of record on Tuesday, December 5th will be given a dividend of $0.70 per share. This represents a $2.80 annualized dividend and a dividend yield of 1.24%. The ex-dividend date of this dividend is Monday, December 4th. Anthem’s dividend payout ratio is currently 25.32%.

Anthem declared that its board has authorized a stock buyback plan on Thursday, December 7th that authorizes the company to buyback $5.00 billion in outstanding shares. This buyback authorization authorizes the company to reacquire shares of its stock through open market purchases. Shares buyback plans are often an indication that the company’s board believes its stock is undervalued.

In other Anthem news, Chairman Joseph Swedish sold 21,125 shares of the company’s stock in a transaction on Friday, December 1st. The stock was sold at an average price of $231.43, for a total value of $4,888,958.75. Following the transaction, the chairman now owns 87,668 shares of the company’s stock, valued at approximately $20,289,005.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Ronald W. Penczek sold 978 shares of the company’s stock in a transaction on Tuesday, November 7th. The shares were sold at an average price of $217.42, for a total value of $212,636.76. Following the completion of the transaction, the senior vice president now directly owns 1,222 shares in the company, valued at approximately $265,687.24. The disclosure for this sale can be found here. In the last three months, insiders have sold 65,955 shares of company stock worth $13,907,287. Corporate insiders own 0.36% of the company’s stock.

A number of institutional investors have recently made changes to their positions in the business. C M Bidwell & Associates Ltd. grew its position in Anthem by 0.5% in the 2nd quarter. C M Bidwell & Associates Ltd. now owns 1,070 shares of the company’s stock valued at $201,000 after acquiring an additional 5 shares during the last quarter. Salem Investment Counselors Inc. grew its position in Anthem by 1.4% in the 2nd quarter. Salem Investment Counselors Inc. now owns 710 shares of the company’s stock valued at $134,000 after acquiring an additional 10 shares during the last quarter. Gofen & Glossberg LLC IL grew its position in Anthem by 0.6% in the 2nd quarter. Gofen & Glossberg LLC IL now owns 2,540 shares of the company’s stock valued at $478,000 after acquiring an additional 15 shares during the last quarter. Stanley Laman Group Ltd. grew its position in Anthem by 0.8% in the 2nd quarter. Stanley Laman Group Ltd. now owns 3,256 shares of the company’s stock valued at $613,000 after acquiring an additional 25 shares during the last quarter. Finally, Parallel Advisors LLC grew its position in Anthem by 1.5% in the 2nd quarter. Parallel Advisors LLC now owns 1,846 shares of the company’s stock valued at $344,000 after acquiring an additional 28 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors.

TRADEMARK VIOLATION NOTICE: This story was reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this story on another site, it was illegally stolen and reposted in violation of US & international copyright and trademark legislation. The original version of this story can be read at https://ledgergazette.com/2017/12/16/investors-buy-shares-of-anthem-antm-on-weakness.html.

About Anthem

Anthem, Inc is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products.

Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply